278 related articles for article (PubMed ID: 10214749)
1. Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis.
Kim S; Liva SM; Dalal MA; Verity MA; Voskuhl RR
Neurology; 1999 Apr; 52(6):1230-8. PubMed ID: 10214749
[TBL] [Abstract][Full Text] [Related]
2. Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response.
Dalal M; Kim S; Voskuhl RR
J Immunol; 1997 Jul; 159(1):3-6. PubMed ID: 9200430
[TBL] [Abstract][Full Text] [Related]
3. Estriol treatment ameliorates disease in males with experimental autoimmune encephalomyelitis: implications for multiple sclerosis.
Palaszynski KM; Liu H; Loo KK; Voskuhl RR
J Neuroimmunol; 2004 Apr; 149(1-2):84-9. PubMed ID: 15020068
[TBL] [Abstract][Full Text] [Related]
4. Treatment of autoimmune disease by oral tolerance to autoantigens.
Whitacre CC; Gienapp IE; Meyer A; Cox KL; Javed N
Clin Immunol Immunopathol; 1996 Sep; 80(3 Pt 2):S31-9. PubMed ID: 8811061
[TBL] [Abstract][Full Text] [Related]
5. Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains.
Bebo BF; Fyfe-Johnson A; Adlard K; Beam AG; Vandenbark AA; Offner H
J Immunol; 2001 Feb; 166(3):2080-9. PubMed ID: 11160259
[TBL] [Abstract][Full Text] [Related]
6. Role of Th1 and Th2 cells in autoimmune demyelinating disease.
Nagelkerken L
Braz J Med Biol Res; 1998 Jan; 31(1):55-60. PubMed ID: 9686179
[TBL] [Abstract][Full Text] [Related]
7. [Mechanisms involved in the regulation of immune response in experimental autoimmune encephalomyelitis in mice].
Tutaj M; Szczepanik M
Postepy Hig Med Dosw (Online); 2006; 60():571-83. PubMed ID: 17115007
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulatory effect of combination therapy with lovastatin and 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside alleviates neurodegeneration in experimental autoimmune encephalomyelitis.
Paintlia AS; Paintlia MK; Singh I; Singh AK
Am J Pathol; 2006 Sep; 169(3):1012-25. PubMed ID: 16936274
[TBL] [Abstract][Full Text] [Related]
10. Th Cell Diversity in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
Carbajal KS; Mironova Y; Ulrich-Lewis JT; Kulkarni D; Grifka-Walk HM; Huber AK; Shrager P; Giger RJ; Segal BM
J Immunol; 2015 Sep; 195(6):2552-9. PubMed ID: 26238492
[TBL] [Abstract][Full Text] [Related]
11. An acidic polysaccharide of Panax ginseng ameliorates experimental autoimmune encephalomyelitis and induces regulatory T cells.
Hwang I; Ahn G; Park E; Ha D; Song JY; Jee Y
Immunol Lett; 2011 Aug; 138(2):169-78. PubMed ID: 21524666
[TBL] [Abstract][Full Text] [Related]
12. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
Jee Y; Liu R; Bai XF; Campagnolo DI; Shi FD; Vollmer TL
Int Immunol; 2006 Apr; 18(4):537-44. PubMed ID: 16481342
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response.
Matsushita T; Fujimoto M; Hasegawa M; Komura K; Takehara K; Tedder TF; Sato S
Am J Pathol; 2006 Mar; 168(3):812-21. PubMed ID: 16507897
[TBL] [Abstract][Full Text] [Related]
14. B-cell responses to myelin basic protein and its epitopes in autoimmune encephalomyelitis induced by Semple rabies vaccine.
Piyasirisilp S; Hemachudha T; Griffin DE
J Neuroimmunol; 1999 Aug; 98(2):96-104. PubMed ID: 10430042
[TBL] [Abstract][Full Text] [Related]
15. Thymic peptides restrain the inflammatory response in mice with experimental autoimmune encephalomyelitis.
Lunin SM; Glushkova OV; Khrenov MO; Novoselova TV; Parfenyuk SB; Fesenko EE; Novoselova EG
Immunobiology; 2013 Mar; 218(3):402-7. PubMed ID: 22727332
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory effects and improved prognosis of experimental autoimmune encephalomyelitis after O-tetradecanoyl-genistein treatment.
Castro SB; Junior CO; Alves CC; Dias AT; Alves LL; Mazzoccoli L; Mesquita FP; Figueiredo NS; Juliano MA; Castañon MC; Gameiro J; Almeida MV; Teixeira HC; Ferreira AP
Int Immunopharmacol; 2012 Feb; 12(2):465-70. PubMed ID: 22245971
[TBL] [Abstract][Full Text] [Related]
17. Complexities of applying nasal tolerance induction as a therapy for ongoing relapsing experimental autoimmune encephalomyelitis (EAE) in DA rats.
Bai XF; Li HL; Shi FD; Liu JQ; Xiao BG; Van der Meide PH; Link H
Clin Exp Immunol; 1998 Jan; 111(1):205-10. PubMed ID: 9472683
[TBL] [Abstract][Full Text] [Related]
18. Suppression of ongoing experimental allergic encephalomyelitis (EAE) in Lewis rats: synergistic effects of myelin basic protein (MBP) peptide 68-86 and IL-4.
Xu LY; Huang YM; Yang JS; Van Der Meide PH; Link H; Xiao BG
Clin Exp Immunol; 2000 Jun; 120(3):526-31. PubMed ID: 10844533
[TBL] [Abstract][Full Text] [Related]
19. Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERalpha).
Gold SM; Sasidhar MV; Morales LB; Du S; Sicotte NL; Tiwari-Woodruff SK; Voskuhl RR
Lab Invest; 2009 Oct; 89(10):1076-83. PubMed ID: 19668239
[TBL] [Abstract][Full Text] [Related]
20. Acute treatment with valproic acid and l-thyroxine ameliorates clinical signs of experimental autoimmune encephalomyelitis and prevents brain pathology in DA rats.
Castelo-Branco G; Stridh P; Guerreiro-Cacais AO; Adzemovic MZ; Falcão AM; Marta M; Berglund R; Gillett A; Hamza KH; Lassmann H; Hermanson O; Jagodic M
Neurobiol Dis; 2014 Nov; 71():220-33. PubMed ID: 25149263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
